Risk of Intracranial Hemorrhage with Direct Oral Anticoagulants (DOACs) Versus Low Molecular Weight Heparin (LMWH) in Primary and Secondary Brain Cancers: An up-to-Date Meta-Analysis of Comparative Studies

Risk of Intracranial Hemorrhage with Direct Oral Anticoagulants (DOACs) Versus Low Molecular Weight Heparin (LMWH) in Primary and Secondary Brain Cancers: An up-to-Date Meta-Analysis of Comparative Studies

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Blood 2022-11, Vol.140 (Supplement 1), p.5677-5677
Hauptverfasser: Haddad, Philip A, Graham, Christopher, Hammoud, Dalia
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 5677
container_issue Supplement 1
container_start_page 5677
container_title Blood
container_volume 140
creator Haddad, Philip A
Graham, Christopher
Hammoud, Dalia
description
doi_str_mv 10.1182/blood-2022-157409
format Article
fullrecord <record><control><sourceid>elsevier_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1182_blood_2022_157409</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0006497122040587</els_id><sourcerecordid>S0006497122040587</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1379-ee7c2b5b94500ada1ed0fdd133234cfb11521ea9e15e1d93a9f65a96b6a435783</originalsourceid><addsrcrecordid>eNp9UcFuEzEQtRBIhMIHcJtje3CxvbvZLJzCBkilREEU6HE1a88mho0d2U6rfiT_hNNw5jQzenpv3sxj7K0U11LO1Lt-9N5wJZTisqpL0TxjE1mpGRdCiedsIoSY8rKp5Uv2KsZfQsiyUNWE_flm42_wA9y4FFAHdBZHWNLeh7DDLcGDTTtY2EA6wSZkbO6S1R63xxFdinC52MzbeAU_KcRjhJV_gLUfSWc4wB3Z7S5luQMG6-Bytb5bXkHuvga7x_AI6AzckvbOnKaPATPWotNZ7H3eBMcDT54vMBGsKSGfOxwfo40nx63fZ1lM9p7gNh2NpfiavRhwjPTmX71gPz5_-t4u-Wrz5aadr7iWRd1wolqrvuqbshICDUoyYjBGFoUqSj30Mn9OEjYkK5KmKbAZphU2036KZVHVs-KCybOuDj7GQEN3OB_USdGd8uie8uhOeXTnPDLnw5lD2di9pdBFbSmfap6e2xlv_8P-CxaElZI</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Risk of Intracranial Hemorrhage with Direct Oral Anticoagulants (DOACs) Versus Low Molecular Weight Heparin (LMWH) in Primary and Secondary Brain Cancers: An up-to-Date Meta-Analysis of Comparative Studies</title><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Haddad, Philip A ; Graham, Christopher ; Hammoud, Dalia</creator><creatorcontrib>Haddad, Philip A ; Graham, Christopher ; Hammoud, Dalia</creatorcontrib><identifier>ISSN: 0006-4971</identifier><identifier>EISSN: 1528-0020</identifier><identifier>DOI: 10.1182/blood-2022-157409</identifier><language>eng</language><publisher>Elsevier Inc</publisher><ispartof>Blood, 2022-11, Vol.140 (Supplement 1), p.5677-5677</ispartof><rights>2022 The American Society of Hematology</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Haddad, Philip A</creatorcontrib><creatorcontrib>Graham, Christopher</creatorcontrib><creatorcontrib>Hammoud, Dalia</creatorcontrib><title>Risk of Intracranial Hemorrhage with Direct Oral Anticoagulants (DOACs) Versus Low Molecular Weight Heparin (LMWH) in Primary and Secondary Brain Cancers: An up-to-Date Meta-Analysis of Comparative Studies</title><title>Blood</title><issn>0006-4971</issn><issn>1528-0020</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNp9UcFuEzEQtRBIhMIHcJtje3CxvbvZLJzCBkilREEU6HE1a88mho0d2U6rfiT_hNNw5jQzenpv3sxj7K0U11LO1Lt-9N5wJZTisqpL0TxjE1mpGRdCiedsIoSY8rKp5Uv2KsZfQsiyUNWE_flm42_wA9y4FFAHdBZHWNLeh7DDLcGDTTtY2EA6wSZkbO6S1R63xxFdinC52MzbeAU_KcRjhJV_gLUfSWc4wB3Z7S5luQMG6-Bytb5bXkHuvga7x_AI6AzckvbOnKaPATPWotNZ7H3eBMcDT54vMBGsKSGfOxwfo40nx63fZ1lM9p7gNh2NpfiavRhwjPTmX71gPz5_-t4u-Wrz5aadr7iWRd1wolqrvuqbshICDUoyYjBGFoUqSj30Mn9OEjYkK5KmKbAZphU2036KZVHVs-KCybOuDj7GQEN3OB_USdGd8uie8uhOeXTnPDLnw5lD2di9pdBFbSmfap6e2xlv_8P-CxaElZI</recordid><startdate>20221115</startdate><enddate>20221115</enddate><creator>Haddad, Philip A</creator><creator>Graham, Christopher</creator><creator>Hammoud, Dalia</creator><general>Elsevier Inc</general><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20221115</creationdate><title>Risk of Intracranial Hemorrhage with Direct Oral Anticoagulants (DOACs) Versus Low Molecular Weight Heparin (LMWH) in Primary and Secondary Brain Cancers: An up-to-Date Meta-Analysis of Comparative Studies</title><author>Haddad, Philip A ; Graham, Christopher ; Hammoud, Dalia</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1379-ee7c2b5b94500ada1ed0fdd133234cfb11521ea9e15e1d93a9f65a96b6a435783</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Haddad, Philip A</creatorcontrib><creatorcontrib>Graham, Christopher</creatorcontrib><creatorcontrib>Hammoud, Dalia</creatorcontrib><collection>CrossRef</collection><jtitle>Blood</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Haddad, Philip A</au><au>Graham, Christopher</au><au>Hammoud, Dalia</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Risk of Intracranial Hemorrhage with Direct Oral Anticoagulants (DOACs) Versus Low Molecular Weight Heparin (LMWH) in Primary and Secondary Brain Cancers: An up-to-Date Meta-Analysis of Comparative Studies</atitle><jtitle>Blood</jtitle><date>2022-11-15</date><risdate>2022</risdate><volume>140</volume><issue>Supplement 1</issue><spage>5677</spage><epage>5677</epage><pages>5677-5677</pages><issn>0006-4971</issn><eissn>1528-0020</eissn><pub>Elsevier Inc</pub><doi>10.1182/blood-2022-157409</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0006-4971
ispartof Blood, 2022-11, Vol.140 (Supplement 1), p.5677-5677
issn 0006-4971
1528-0020
language eng
recordid cdi_crossref_primary_10_1182_blood_2022_157409
source EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection
title Risk of Intracranial Hemorrhage with Direct Oral Anticoagulants (DOACs) Versus Low Molecular Weight Heparin (LMWH) in Primary and Secondary Brain Cancers: An up-to-Date Meta-Analysis of Comparative Studies
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T19%3A07%3A38IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-elsevier_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Risk%20of%20Intracranial%20Hemorrhage%20with%20Direct%20Oral%20Anticoagulants%20(DOACs)%20Versus%20Low%20Molecular%20Weight%20Heparin%20(LMWH)%20in%20Primary%20and%20Secondary%20Brain%20Cancers:%20An%20up-to-Date%20Meta-Analysis%20of%20Comparative%20Studies&rft.jtitle=Blood&rft.au=Haddad,%20Philip%20A&rft.date=2022-11-15&rft.volume=140&rft.issue=Supplement%201&rft.spage=5677&rft.epage=5677&rft.pages=5677-5677&rft.issn=0006-4971&rft.eissn=1528-0020&rft_id=info:doi/10.1182/blood-2022-157409&rft_dat=%3Celsevier_cross%3ES0006497122040587%3C/elsevier_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rft_els_id=S0006497122040587&rfr_iscdi=true